| 中文名 | 匹格列酮 |
| 英文名 | Pioglitazone |
| 别名 | 匹格列酮;吡格列酮;匹格列酮碱;吡格列酮D4;匹格列酮杂质B;匹格列酮(标准品);5-[4-[2-(5-乙基-2-吡啶)乙氧基]苄基]-2,4-噻唑烷二酮;(±)-5-[[4-[2-(5-乙基-2-吡啶基)乙氧基]苯基]甲基]-2,4-噻唑啉二酮;5-[[4-[2-(5-乙基吡啶-2-基)乙氧基]苯基]甲基]-1,3-噻唑烷-2,4-二酮 |
| CAS | 111025-46-8;105355-27-9 |
| EINECS | 601-029-7 |
| 化学式 | C19H20N2O3S |
| 分子量 | 356.44 |
| inchi | InChI=1/C19H20N2O3S.ClH/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);1H |
| 包装信息 | 5 g |
| 价格 | $259 |
| 产品描述 | 匹格列酮 Pioglitazone is a PPAR agonist that exhibits antidiabetic activity in patients with type 2 diabetes mellitus. It has no effect on type 1 diabetes. |
| 产品链接 | http://www.bocsci.com/product/pioglitazone-cas-111025-46-8-81675.html |
| 更新日期 | 2025-04-30 11:27:47 |